Martingale Asset Management’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $554K | Buy |
87,861
+52,452
| +148% | +$330K | 0.01% | 601 |
|
|
2025
Q1 | $227K | Sell |
35,409
-3,700
| -9% | -$23.7K | 0.01% | 726 |
|
|
2024
Q4 | $314K | Buy |
39,109
+4,123
| +12% | +$33.1K | 0.01% | 683 |
|
|
2024
Q3 | $442K | Sell |
34,986
-1,898
| -5% | -$24K | 0.01% | 648 |
|
|
2024
Q2 | $467K | Sell |
36,884
-21,759
| -37% | -$275K | 0.01% | 611 |
|
|
2024
Q1 | $280K | Buy |
58,643
+18
| +0% | +$86 | 0.01% | 716 |
|
|
2023
Q4 | $281K | Buy |
58,625
+13,218
| +29% | +$63.4K | 0.01% | 715 |
|
|
2023
Q3 | $329K | Buy |
45,407
+15,828
| +54% | +$115K | 0.01% | 674 |
|
|
2023
Q2 | $220K | Buy |
+29,579
| New | +$220K | ﹤0.01% | 750 |
|
|
2021
Q2 | – | Sell |
-7,612
| Closed | -$1.38M | – | 880 |
|
|
2021
Q1 | $1.38M | Sell |
7,612
-1,001
| -12% | -$182K | 0.02% | 345 |
|
|
2020
Q4 | $961K | Sell |
8,613
-300
| -3% | -$33.5K | 0.01% | 454 |
|
|
2020
Q3 | $966K | Sell |
8,913
-100
| -1% | -$10.8K | 0.01% | 647 |
|
|
2020
Q2 | $752K | Buy |
+9,013
| New | +$752K | 0.01% | 801 |
|